Health level seven interoperability strategy: Big data, Incrementally structured

Methods of Information in Medicine

Volumn 54, Issue 1, 2015, Pages 75-82

  Dolin, R H ^a   Rogers, B ^b   Jaffe, C ^c  

^a Apixio Inc Advanced Development Department ^*  (United States)

^b Apixio Inc Advanced Development Department   (United States)

^c Health Level Seven International   (United States)

Author keywords

Big data; CDA; HL7; Semantic Interoperability

Indexed keywords

CODING; ELECTRONIC HEALTH RECORD; HEALTH LEVEL 7; MEANINGFUL USE CRITERIA; MEDICAL RECORD; ORGANIZATION AND MANAGEMENT; UNITED STATES;

CLINICAL CODING; ELECTRONIC HEALTH RECORDS; HEALTH LEVEL SEVEN; MEANINGFUL USE; MEDICAL RECORD LINKAGE; UNITED STATES;

EID: 84921283366     PISSN: 00261270     EISSN: None     Source Type: Journal    
DOI: 10.3414/ME14-01-0030     Document Type: Article

References (14)

1. Dolin RH, Alschuler L, Boyer S, Beebe C, Behlen FM, Biron PV, Shabo A. HL7 Clinical Document Architecture, Release 2. J Am Med Inform Assoc 2006; 13: 30-39 [http://www.jamia.org/cgi/ content/short/13/1/30].
2. Dolin RH, Alschuler L, Boyer S, Beebe C, Behlen FM, Biron PV, Shabo A, editors. HL7 Clinical Document Architecture, Release 2.0. ANSI-approved HL7 Standard, May 2005. Ann Arbor, MI: Health Level Seven, Inc.; 2005 [http://www. hl7.org/implement/standards/product_brief.cfm? product_id=7].
3. Department of Health and Human Services, Office of the National Coordinator for Health Information Technology. Health Information Technology: Standards, Implementation Specifications, and Certification Criteria for Electronic Health Record Technology, 2014 Edition; Revisions to the Permanent Certification Program for Health Informa-tion Technology (ONC Meaningful Use Stage 2 Final Rule). Sept, 2012 [http://www.gpo.gov/fdsys/ pkg/FR-2012–09–04/pdf/2012–20982.pdf].
4. ® R2: Consolidated CDA (C-CDA), Draft Standard for Trial Use Release 1.1; 2012 [http://www.hl7.org/imple ment/standards/product_brief.cfm?product_id= 258].
5. ® R2: Quality Reporting Document Architecture-Category I (QRDA-I), Draft Standard for Trial Use Release 2; 2012 [http://www.hl7.org/implement/standards/ product_brief.cfm?product_id=35].
6. ® R2: Ambulatory Healthcare Provider Reporting to Central Cancer Registries, 2012 [http://www.cdc.gov/ phin/library/guides/Implementation_Guide_for_ Ambulatory_Healthcare_Provider_Reporting_to_ Central_Cancer_Registries_August_2012.pdf].
7. ® Release 2: Quality Reporting Document Architecture-Category III (QRDA-III), Draft Standard for Trial Use Release 1; 2012. [http://www.hl7. org/implement/standards/product_brief.cfm? product_id=286]
8. Healthcare Information and Management Systems Society (HIMSS)’ Health Story Project [http:// www.healthstory.com/].
9. Fung KW, Jao CS, Demner-Fushman D. Extracting drug indication information from structured product labels using natural language processing. J Am Med Inform Assoc 2013; 20: 482-488.
10. Harpaz R, Vilar S, DuMouchel W, et al. Combing signals from spontaneous reports and electronic health records for detection of adverse drug reactions. J Am Med Inform Assoc 2013; 20: 413-419.
11. LePendu P, Iyer SV, Bauer-Mehren A, Harpaz R, Mortensen JM, Podchiyska T, Ferris TA, and Shah NH. Pharmacovigilance Using Clinical Notes. Nature: Clinical Pharmacology & Therapeutics 2013; 93: 547-555.
12. Gandhi TK, Zuccotti G, Lee TH. Incomplete care-on the trail of flaws in the system. NEJM 2011; 365 (6): 486-488. (PMID: 21830964)
13. Apixio White Paper. Big Data Reveals Crucial Hidden Information in Healthcare Systems-Health Technology Use Case. 2013 [http:// apixio.com/big-data-reveals-crucial-hiddeninformation].
14. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719-748.